Ads
related to: eplerenone monitoring system- Real-Time UX Monitoring
Ensure Reliable User Experiences
Across Web And Mobile Applications.
- APM + Service Catalog
Simplify Service Governance
At Scale
- Database Monitoring
Monitor Database Health And
Troubleshoot Performance Issues
- Request A Datadog Demo
Request A Personalized Demo And
Get Access To A Pre-recorded Demo
- Gartner® Magic Quadrant™
2024 Leader For Ability To Execute
And The Completeness Of Vision
- Datadog Free Trial
Sign Up Today For A Free Trial
And See Value Immediately.
- Real-Time UX Monitoring
Search results
Results From The WOW.Com Content Network
Eplerenone is an antimineralocorticoid, or an antagonist of the mineralocorticoid receptor (MR). [21] Eplerenone is also known chemically as 9,11α-epoxy-7α-methoxycarbonyl-3-oxo-17α-pregn-4-ene-21,17-carbolactone and "was derived from spironolactone by the introduction of a 9α,11α-epoxy bridge and by substitution of the 17α-thoacetyl ...
Potassium-sparing diuretics act to prevent sodium reabsorption in the collecting tubule by either binding ENaCs (amiloride, triamterene) or by inhibiting aldosterone receptors (spironolactone, eplerenone). This prevents excessive excretion of K + in urine and decreased retention of water, preventing hypokalemia. [10]
Eplerenone is a newer drug that was developed as a spironolactone analog with reduced adverse effects. In addition to the y-lactone ring and the substituent on C-7, eplerenone has a 9α,11α-epoxy group. This group is believed to be the reason why eplerenone has a 20-40-fold lower affinity for the mineralocorticoid receptor than spironolactone. [7]
Antihypertensive agents comprise multiple classes of compounds that are intended to manage hypertension (high blood pressure). Antihypertensive therapy aims to maintain a blood pressure goal of <140/90 mmHg in all patients, as well as to prevent the progression or recurrence of cardiovascular diseases (CVD) in hypertensive patients with established CVD. [2]
Eplerenone is specifically indicated for post-MI reduction of cardiovascular risk. If a heart failure patient exhibits a resistance to or poor response to diuretic therapy, ultrafiltration or aquapheresis may be needed to achieve adequate control of fluid retention and congestion. The use of such mechanical methods of fluid removal can produce ...
Eplerenone, a steroidal antimineralocorticoid of the spirolactone group; Estriol triacetate, an estrogen medication and an estrogen ester
Ads
related to: eplerenone monitoring system